We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$461B
AUM Growth
+$24.9B
Cap. Flow
-$12.1B
Cap. Flow %
-2.62%
Top 10 Hldgs %
40.03%
Holding
5,800
New
615
Increased
1,596
Reduced
2,751
Closed
340

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.34B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.65B
3
TSLA icon
Tesla
TSLA
+$1.45B
4
QQQ icon
Invesco QQQ Trust
QQQ
+$1.01B
5
AAPL icon
Apple
AAPL
+$833M

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Financials 7.27%
3 Consumer Discretionary 6.82%
4 Communication Services 5.06%
5 Healthcare 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTAI icon
5376
BioXcel Therapeutics
BTAI
$24.8M
-8
Closed -$14
CARM
5377
DELISTED
Carisma Therapeutics
CARM
-100
Closed -$39
CARR icon
5378
CALL
Carrier Global
CARR
$49.8B
-866,300
Closed -$63.4M
CCAP icon
5379
Crescent Capital BDC
CCAP
$405M
-26,003
Closed -$367K
CDTX
5380
CALL
DELISTED
Cidara Therapeutics
CDTX
-75,000
Closed -$3.65M
CDTX
5381
PUT
DELISTED
Cidara Therapeutics
CDTX
-75,000
Closed -$3.65M
CHDN icon
5382
PUT
Churchill Downs
CHDN
$6.17B
-139,800
Closed -$14.1M
CHT icon
5383
Chunghwa Telecom
CHT
$33.5B
-818
Closed -$38.1K
CHX
5384
DELISTED
ChampionX
CHX
-416,479
Closed -$10.3M
CIB icon
5385
Grupo Cibest SA
CIB
$21.2B
-26,400
Closed -$1.22M
CIG icon
5386
CEMIG Preferred Shares
CIG
$6.06B
-342,338
Closed -$671K
CL icon
5387
PUT
Colgate-Palmolive
CL
$74.8B
-76,700
Closed -$6.97M
CLBR
5388
DELISTED
Colombier Acquisition Corp II
CLBR
-101,860
Closed -$1.57M
CLOZ icon
5389
Panagram BBB-B CLO ETF
CLOZ
$783M
-318,582
Closed -$8.52M
CMI icon
5390
CALL
Cummins
CMI
$83.6B
-3,600
Closed -$1.18M
CNK icon
5391
CALL
Cinemark Holdings
CNK
$4.07B
-60,100
Closed -$1.81M
COGT icon
5392
CALL
Cogent Biosciences
COGT
$6.76B
-79,000
Closed -$567K
CPA icon
5393
Copa Holdings
CPA
$5.56B
-2,200
Closed -$242K
CPHC icon
5394
Canterbury Park Holding Corp
CPHC
$80.2M
-17
Closed -$320
CPIX icon
5395
Cumberland Pharmaceuticals
CPIX
$99.8M
-2
Closed -$7
CR icon
5396
CALL
Crane Co
CR
$11.9B
-22,500
Closed -$4.27M
CRDO icon
5397
PUT
Credo Technology Group
CRDO
$33.1B
-874,400
Closed -$81M
CRGX
5398
DELISTED
CARGO Therapeutics
CRGX
-63,260
Closed -$261K
CRS icon
5399
CALL
Carpenter Technology
CRS
$26.4B
-35,000
Closed -$9.67M
CSWC icon
5400
Capital Southwest
CSWC
$1.47B
-24,717
Closed -$545K

Similar funds

Barclays's Q3 2025 Portfolio in Review

As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
  • Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
  • Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
  • Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
  • Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
  • Barclays opened 615 new positions and closed 340 in Q3 2025.
  • Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.